May 5, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Kohl’s Corporation (“Kohl’s” or “the Company”) (NYSE: KSS). Investors who purchased Kohl’s securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Kohl’s has violated federal… read more
May 2, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Arvinas, Inc. (“Arvinas” or “the Company”) (NASDAQ: ARVN). Investors who purchased Arvinas securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Arvinas has violated federal… read more
May 2, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Humana Inc. (“Humana” or “the Company”) (NYSE: HUM). Investors who purchased Humana securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Humana has violated federal… read more
May 1, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Wabash National Corporation (“Wabash” or “the Company”) (NYSE: WNC). Investors who purchased Wabash securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Wabash has violated… read more
April 30, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of D-Wave Quantum Inc. (“D-Wave” or “the Company”) (NYSE: QBTS). Investors who purchased D-Wave securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether D-Wave has violated… read more
April 30, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Teleflex Incorporated (“Teleflex” or “the Company”) (NYSE: TFX). Investors who purchased Teleflex securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Teleflex has violated federal… read more
April 29, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of FTI Consulting, Inc. (“FTI” or “the Company”) (NYSE: FCN). Investors who purchased FTI securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether FTI has violated… read more
April 29, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of T-Mobile US, Inc. (“T-Mobile” or “the Company”) (NASDAQ: TMUS). Investors who purchased T-Mobile securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether T-Mobile has violated… read more
April 28, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Manhattan Associates, Inc. (“Manhattan Associates” or “the Company”) (NASDAQ: MANH). Investors who purchased Manhattan Associates securities prior to October 22, 2024, and continue to hold to the present, are encouraged to… read more
April 28, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Landstar System, Inc. (“Landstar” or “the Company”) (NASDAQ: LSTR). Investors who purchased Landstar securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Landstar has violated… read more
April 25, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ICU Medical, Inc. (“ICU Medical” or “the Company”) (NASDAQ: ICUI). Investors who purchased ICU Medical securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether ICU… read more
April 24, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Backblaze, Inc. (“Backblaze” or “the Company”) (NASDAQ: BLZE). Investors who purchased Backblaze securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Backblaze has violated federal… read more
April 23, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Northrop Grumman Corporation (“Northrop Grumman” or “the Company”) (NYSE: NOC). Investors who purchased Northrop Grumman securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Northrop… read more
April 23, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Venture Global, Inc. (“Venture Global” or “the Company”) (NYSE: VG). Investors who purchased Venture Global securities pursuant to the registration statement and prospectus issued in connection with the Company’s January 24,… read more
April 23, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Atkore Inc. (“Atkore” or “the Company”) (NYSE: ATKR). Investors who purchased Atkore securities prior to February 17, 2021, and continue to hold to the present, are encouraged to obtain additional information… read more
April 22, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Semtech Corporation (“Semtech” or “the Company”) (NASDAQ: SMTC). Investors who purchased Semtech securities prior to August 27, 2024, and continue to hold to the present, are encouraged to obtain additional information… read more
April 22, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Gorilla Technology Group Inc. (“Gorilla” or “the Company”) (NASDAQ: GRRR). Investors who purchased Gorilla securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Gorilla has… read more
April 22, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Kyndryl Holdings, Inc. (“Kyndryl” or “the Company”) (NYSE: KD). Investors who purchased Kyndryl securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Kyndryl has violated… read more
April 21, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Uber Technologies, Inc. (“Uber” or “the Company”) (NYSE: UBER). Investors who purchased Uber securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Uber has violated… read more
April 21, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Agilysys, Inc. (“Agilysys” or “the Company”) (NASDAQ: AGYS). Investors who purchased Agilysys securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Agilysys has violated federal… read more
April 17, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Movado Group, Inc. (“Movado Group” or “the Company”) (NYSE: MOV). Investors who purchased Movado Group securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Movado… read more
April 16, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Allbirds, Inc. (“Allbirds” or “the Company”) (NASDAQ: BIRD). Investors who purchased Allbirds securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Allbirds has violated federal… read more
April 16, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of TransMedics Group, Inc. (“TransMedics” or “the Company”) (NASDAQ: TMDX). Investors who purchased TransMedics securities prior to February 3, 2022, and continue to hold to the present, are encouraged to obtain additional… read more
April 16, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of FMC Corporation (“FMC” or “the Company”) (NYSE: FMC). Investors who purchased FMC securities prior to November 16, 2023, and continue to hold to the present, are encouraged to obtain additional information… read more
April 15, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Adverum Biotechnologies, Inc. (“Adverum” or “the Company”) (NASDAQ: ADVM). Investors who purchased Adverum securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Adverum has violated… read more
April 15, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of The Greenbrier Companies, Inc. (“Greenbrier” or “the Company”) (NYSE: GBX). Investors who purchased Greenbrier securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Greenbrier has… read more
April 8, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of TechTarget, Inc. (“TechTarget” or “the Company”) (NASDAQ: TTGT). Investors who purchased TechTarget securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether TechTarget has violated federal… read more
April 7, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of DuPont de Nemours, Inc. (“DuPont” or “the Company”) (NYSE: DD). Investors who purchased DuPont securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether DuPont has… read more
April 7, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Nyxoah S.A. (“Nyxoah” or “the Company”) (NASDAQ: NYXH). Investors who purchased Nyxoah securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Nyxoah has violated federal… read more
April 3, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Aldeyra Therapeutics, Inc. (“Aldeyra” or “the Company”) (NASDAQ: ALDX). Investors who purchased Aldeyra securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Aldeyra has violated… read more
